Terms: = Prostate cancer AND TRA
13 results:
1. Selective ablation of tra-1-60
White JM; Ramos N; Saliganan AD; Chung JY; Bell M; Lindquist J; Conner K; Wiesend WN; Schopperle M; Patrick SM; Kim S; Heath EI; Escorcia FE; Viola NT
Theranostics; 2023; 13(7):2057-2071. PubMed ID: 37153742
[No Abstract] [Full Text] [Related]
2. An unusual case of oedematous prostate volumetric changes observed over the course of radiotherapy on the MR linear accelerator.
Clough A; Bridge P; Hales R; McDaid L; Choudhury A; Eccles CL
J Med Imaging Radiat Sci; 2021 Mar; 52(1):147-151. PubMed ID: 33342695
[TBL] [Abstract] [Full Text] [Related]
3. Detecting tra-1-60 in cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent.
White JM; Kuda-Wedagedara AN; Wicker MN; Spratt DE; Schopperle WM; Heath E; Viola NT
Mol Pharm; 2020 Apr; 17(4):1139-1147. PubMed ID: 32069422
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Detection of Pathogens Causing Sexually transmissible Infections in Patients with prostate cancer and Hyperplasia by Quantitative TaqMan Real-Time PCR Assay.
Ala-Almohadesin A; Mohammadbeygi M; Bahavar A; Mohammadi MA; Mohamadzadeh N; Abolhasani M; Dabiri H
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307183
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in prostate cancer.
Heath EI; Heilbrun LK; Smith D; Schopperle WM; Ju Y; Bolton S; Ahmed Q; Sakr WA
Anticancer Res; 2018 Nov; 38(11):6361-6366. PubMed ID: 30396958
[TBL] [Abstract] [Full Text] [Related]
6. Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble traIL in prostate cancer.
Arafat W; Zhou T; Naoum GE; Buchsbaum DJ
J Egypt Natl Canc Inst; 2015 Dec; 27(4):205-15. PubMed ID: 26385392
[TBL] [Abstract] [Full Text] [Related]
7. Central T cell tolerance: Identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome.
Alvarez I; Collado JA; Colobran R; Carrascal M; Ciudad MT; Canals F; James EA; Kwok WW; Gärtner M; Kyewski B; Pujol-Borrell R; Jaraquemada D
J Autoimmun; 2015 Jun; 60():12-9. PubMed ID: 25911201
[TBL] [Abstract] [Full Text] [Related]
8. Sorafenib sensitizes solid tumors to Apo2L/traIL and Apo2L/traIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.
Abdulghani J; Allen JE; Dicker DT; Liu YY; Goldenberg D; Smith CD; Humphreys R; El-Deiry WS
PLoS One; 2013; 8(9):e75414. PubMed ID: 24086526
[TBL] [Abstract] [Full Text] [Related]
9. Embryonic stem cell-like cells derived from adult human testis.
Mizrak SC; Chikhovskaya JV; Sadri-Ardekani H; van Daalen S; Korver CM; Hovingh SE; Roepers-Gajadien HL; Raya A; Fluiter K; de Reijke TM; de la Rosette JJ; Knegt AC; Belmonte JC; van der Veen F; de Rooij DG; Repping S; van Pelt AM
Hum Reprod; 2010 Jan; 25(1):158-67. PubMed ID: 19815622
[TBL] [Abstract] [Full Text] [Related]
10. transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract] [Full Text] [Related]
11. The modified firefly luciferase reporter gene (luc+) but not Renilla luciferase is induced by all-trans retinoic acid in MCF-7 breast cancer cells.
Kogai T; Kanamoto Y; Brent GA
Breast Cancer Res Treat; 2003 Mar; 78(1):119-26. PubMed ID: 12611464
[TBL] [Abstract] [Full Text] [Related]
12. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative.
Gao M; Ossowski L; Ferrari AC
J Cell Physiol; 1999 Jun; 179(3):336-46. PubMed ID: 10228952
[TBL] [Abstract] [Full Text] [Related]
13. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type.
Lu XP; Fanjul A; Picard N; Shroot B; Pfahl M
Int J Cancer; 1999 Jan; 80(2):272-8. PubMed ID: 9935210
[TBL] [Abstract] [Full Text] [Related]
